About Us
Driving Innovation in Pharmaceuticals
At Sinopep, we are committed to advancing the frontiers of peptides, oligonucleotides, and small molecules as transformative therapeutic solutions. As a leader in pharmaceutical research, development, and manufacturing, we aim to set new standards across the industry. Our relentless focus on innovation, operational excellence, and scalable manufacturing has positioned us at the forefront of the global pharmaceutical landscape—delivering life-saving solutions and driving progress for our partners worldwide.
- Years Experience
- -
- Employees
- -
- Capacity (MT/yr)
- -
- GMP Faclities
- -
Why Choose Sinopep?
Large-Scale Automated Peptide Manufacturing
Large-scale automated peptide synthesis delivers superior efficiency, consistency, and scalability in producing complex peptide therapeutics. Sinopep’s advanced TIDEs Platform integrates solid- and liquid-phase synthesis to overcome traditional bottlenecks, enabling precisely controlled reactions that achieve exceptional yield, purity, and reproducibility. Automation minimizes human error, shortens production time, and enhances safety while maintaining stringent quality standards. By uniting intelligent process control with cutting-edge synthesis technologies, Sinopep ensures a streamlined, reliable manufacturing process that meets the growing global demand for high-quality peptide medicines.
Setting the Standard Among CDMO Partners in Advanced Manufacturing:
Large-Scale Automation
Central Control Room
Advanced DCS Automation
Intelligent & Close Control System
OEB5 Level Occupational Exposure
Our Services
Sinopep Biopharma is a trusted full-service Peptide and Oligo CDMO offering comprehensive end-to-end CMC development and commercial manufacturing solutions for global partners.
